A Network Meta‐Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs

Nicholas Streicher, Michelle Mezei, Marco Luigetti

Open source

DOI
10.1111/ene.70727
Published
2026-08
Container
European Journal of Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ene.70727,
  title = {A Network Meta‐Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs},
  author = {Nicholas Streicher and Michelle Mezei and Marco Luigetti},
  year = {2026},
  journal = {European Journal of Neurology},
  doi = {10.1111/ene.70727},
  url = {https://doi.org/10.1111/ene.70727}
}

RIS

TY  - JOUR
TI  - A Network Meta‐Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs
AU  - Nicholas Streicher
AU  - Michelle Mezei
AU  - Marco Luigetti
PY  - 2026
JO  - European Journal of Neurology
DO  - 10.1111/ene.70727
UR  - https://doi.org/10.1111/ene.70727
ER  - 

APA

Streicher, N., Mezei, M., & Luigetti, M. (2026). A Network Meta‐Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs. European Journal of Neurology. https://doi.org/10.1111/ene.70727

Source records